Kenneth Bilchick headshot

Kenneth C. Bilchick

Unit: School of Medicine
Department: Department of Medicine, Cardiovascular Medicine
Office location and address
Heart and Vascular Center
1215 Lee St
Charlottesville, Virginia 22903
Residency, Internal Medicine, Johns Hopkins Hospital
Clinical Fellowship, Cardiology & Cardiac Electrophysiology, Johns Hopkins Hospital
MD, Johns Hopkins University

Dr. Bilchick specializes in cardiac rhythm problems, including atrial fibrillation, atrial flutter, supraventricular tachycardia (SVT), and ventricular tachycardia (VT). He performs a full range of procedures to help correct rapid or irregular heart rhythms, which can cause a variety of symptoms (e.g., fatigue, shortness of breath, chest pain, light-headedness, fainting). During catheter ablation procedures, areas of the heart causing rhythm abnormalities are targeted in order to restore normal heart rhythm. Dr. Bilchick also has advanced expertise in pacemakers, defibrillators (ICDs), and cardiac resynchronization therapy (CRT). During his time at UVA, he has developed a tailored pre-op and post-op protocol for patients receiving CRT to improve heart failure symptoms.

Dr. Bilchick maintains an active research program in the use of cardiac magnetic resonance imaging (CMR) for patients with arrhythmias and heart failure; evaluation of advanced treatment options for atrial fibrillation; and outcomes evaluation in Medicare patients with heart rhythm disorders and heart failure. He has found that CMR -- the gold standard for evaluation of cardiac function and scar -- is very useful to helping to guide therapy for heart rhythm patients, because many of these patients have scarring in the heart or abnormal heart function. Dr. Bilchick has a grant from the National Institutes of Health aimed at using CMR to improve outcomes for patients with heart failure who qualify for CRT. He is also involved in integrating CMR technology with ablation of atrial fibrillation at UVA, developing new atrial fibrillation ablation protocols, and evaluating new drugs for atrial fibrillation. A recent publication of his discussing Medicare outcomes attracted widespread interest and is influencing practice in this area.

Dr. Bilchick has an MS degree from the University of Virginia in patient-oriented clinical research, and is the author of over 30 peer-reviewed publications. He continues to pursue patient-oriented research to help offer the latest technology and procedures to patients with heart rhythm disorders and heart failure.

Dr. Bilchick has lived in Spain, Latin America and the Middle East and speaks Spanish fluently. He enjoys spending time with his family, being outdoors and playing the piano.

Multiscale Models for Predicting Short and Long-term Outcome of Cardiac Resynchronization Therapy
Source: U.S. NIH Heart, Lung, And Blood Institute
August 13, 2021 – July 31, 2025
Stimulation Of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in Non-Responders and Previously Untreatable Patients (SOLVE CRT)
Source: EBR Systems, Inc.
February 06, 2020 – February 05, 2023
MD-INMD-CARD Medtronic Adapt Response Study
Source: Medtronic Inc.
December 18, 2014 – December 31, 2022
Source: Siemens Medical Solutions USA, Inc.
October 01, 2018 – December 20, 2022
Personalized Approach to Cardiac Resynchronization Therapy using High Dimensional Immunophenotyping
Source: American Heart Association
July 01, 2018 – June 30, 2022
Pacing With Ultrasound (PACE-US) Study
Source: Medtronic Inc.
April 16, 2019 – April 15, 2022
Use of Electromechanical Activation Findings to Maximize Left Ventricular Functional Improvement from Cardiac Resynchronization Therapy
Source: Medtronic Inc.
May 03, 2017 – January 10, 2022
Risk Stratification for ICD Generator Changes in the ICD Registry
Source: U.S. NIH Heart, Lung, And Blood Institute
August 01, 2018 – July 31, 2021
MD-INMD-CV St. Jude Medical Product Longevity and Performance Registry
Source: Pacesetter, Inc.
December 02, 2014 – December 31, 2020
MRI of Mechanical Activation and Scar for Optimal Cardiac Resynchronization Therapy Implementation
Source: U.S. NIH Heart, Lung, And Blood Institute
September 01, 2017 – August 31, 2020
Optimization of Outcomes with CRT Upgrades Using MRI and Noninvasive Mapping of Electrical Activation
Source: American Heart Association
July 01, 2017 – June 30, 2020
MD-INMD-Cardiac Magnetic Resonance Imaging After Cardiac Resynchronization Therapy
Source: U.S. NIH Heart, Lung, And Blood Institute
September 16, 2016 – June 30, 2019
MD-INMD-CV692-St Jude Med SJ4
Source: St. Jude Medical Cardiac Rhythm Management Divisio
September 01, 2009 – July 26, 2016
MD-INMD-CV-692-NIH-Cardiac Magnetic Resonance Imaging and Cardiac Resynchronization Therapy
Source: U.S. NIH Heart, Lung, And Blood Institute
July 08, 2009 – February 28, 2015
Source: Medtronic Inc.
June 18, 2013 – September 25, 2014
MD-INMD-CV967-EchoCRT Biotronik
Source: BIOTRONIK Inc.
August 18, 2011 – June 30, 2014
MD-INMD-CV692-Hestia-Sanofi-Aventis Effects of Dronedarone on Atrial Fibrillation Burden in Subjects with Permanent Pacemakers
Source: Sanofi-Aventis U.S. Inc.
May 06, 2011 – May 05, 2014
Effects of Dronedarone on Cardiac Geometry and Function in Patients with Atrial Fibrillation and Left Atrial Enlargement
Source: Sanofi-Aventis U.S. Inc.
March 31, 2011 – May 30, 2013